Memorial Medical Center

Las Cruces, New Mexico 88011

2 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumors, Ampullary Cancer, Biliary Tract Cancer, Cholangiocarcinoma, ER Positive, Her2 Negative Breast Cancer Patients, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gall Bladder Cancer, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer, Multiple Myeloma, Non Squamous Lung Cancer

Studies at this site

• The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study — Recruiting now
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) — Running, not enrolling
• VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer — Completed
• A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung — Completed
• A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer — Completed